New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Healthcare Realty Trust Incorporated

HR

Real Estate Reit Healthcare Facilities

Healthcare Realty Trust Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 6.92% from fiscal 2024.

Revenue
−3.74%
EPS
n/m
Free cash flow
−65.2%
Total debt
+2.51%

Quarter to September 2026, against a year earlier

19.38 0.02 +0.10%

After hours trading: 19.36, down 0.10%, last trade 4:01pm Eastern.

Market cap
$6.6B
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
4.95%
F-score
5/9
ROIC
2.19%
Net debt / EBITDA
0.1×
Payout ratio
—

Revenue to profit Q3 FY2026, quarter to Sep 30, 2026

It lost $15.9M on $286.6M of revenue: $5.53 for every $100. What is an income statement?

Revenue to profit, in millions of dollars and as a share of revenue
Revenue286.6100.0%
Cost of revenue−102.4−35.7%
Gross profit184.264.3%
Selling, general & admin−12.4−4.3%
Other operating costs−129.8−45.3%
Operating income42.014.6%
Other income, net−57.8−20.2%
Net income−15.9−5.5%
RevenueOperating incomeNet incomeNet margin (right axis)
Revenue, operating income and net income, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Revenue$286M$279M$282M$287M
Operating income$34M$32M$39M$42M
Net income$15M$0−$44M−$16M
Net margin (right axis)5.1%0.0%−15.6%−5.5%
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Revenue
286.64 281.85 278.99 286.30

+8 more quarters

Revenue Growth
(3.74%) (5.26%) (6.69%) (7.57%)
Cost of Revenue
102.45 98.98 100.06 127.32
Gross Profit
184.20 182.87 178.93 158.98
SG&A Expenses
12.44 14.36 17.34 13.79
Operating Income
41.97 38.97 31.67 34.08
Non-operating Interest Expenses
44.85 45.15 43.89 48.19
Non-operating Income/Expense
(57.82) (82.92) (31.65) (19.48)
EBT
(15.85) (43.95) 0.02 14.59
Income after Tax
(15.85) (43.95) 0.02 14.59
Non-Controlling Interest
(0.10) (0.44) 0.08 0.20
Net Income Common
(15.75) (43.51) (0.06) 14.39
EPS (Basic)
(0.05) (0.13) 0.00 0.04
EPS (Diluted)
(0.05) (0.13) 0.00 0.04
Shares (Basic, Weighted)
340.62 342.30 347.44 349.80
Shares (Diluted, Weighted)
340.62 342.30 347.44 349.80
Gross Margin
64.26% 64.88% 64.14% 55.53%
EBIT Margin
14.64% 13.83% 11.35% 11.90%
EBT margin
(5.53%) (15.60%) 0.01% 5.10%
Net Profit Margin
(5.50%) (15.44%) (0.02%) 5.03%
EBITDA
171.96 167.69 164.56 169.23
EBIT
41.97 38.97 31.67 34.08
Income from Continuous Operations
(15.85) (43.95) 0.02 14.59
Consolidated Net Income/Loss
(15.85) (43.95) 0.02 14.59
EPS (Basic, from Continuous Ops)
(0.05) (0.13) 0.00 0.04
EPS (Diluted, from Cont. Ops)
(0.05) (0.13) 0.00 0.04
EPS (Basic, Consolidated)
(0.05) (0.13) 0.00 0.04
EPS (Diluted, Consolidated)
(0.05) (0.13) 0.00 0.04
Shares (Diluted, Average)
340.62 342.30 347.44 350.05
Funds From Operations (FFO)
126.02 123.58 117.17 126.02
EBITDA Margin
59.99% 59.50% 58.98% 59.11%
Operating Cash Flow Margin
42.66% 50.45% 18.95% 46.22%
FFO per Share
0.37 0.36 0.34 0.36

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026